These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 4651413

  • 21. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 22. [Blood level and elimination of ethambutol-dihydrochloride in terminal kidney insufficiency and in hemodialysis].
    Dume T, Wagner C, Wetzels E.
    Verh Dtsch Ges Inn Med; 1971 Apr; 77():1022-5. PubMed ID: 5155955
    [No Abstract] [Full Text] [Related]

  • 23. [Plasma half life of a new cephalosporin in uremic patients].
    Fillastre JP, Humbert G, Malandain H, Dubois D, Daufresne MF, Robert M.
    J Urol Nephrol (Paris); 1973 Apr; 79(4):384. PubMed ID: 4720136
    [No Abstract] [Full Text] [Related]

  • 24. [The elimination of the antibiotic cephacetrile in patients with impaired renal function].
    Spring P, Räber J, Reber H, Dettli L.
    Arzneimittelforschung; 1974 Sep; 24(9b):1462-6. PubMed ID: 4479803
    [No Abstract] [Full Text] [Related]

  • 25. [Preparation and selection of patients with chronic kidney failure for dialysis and kidney transplantation].
    Colombi A, Mannhart M, Massini MA, Thölen H.
    Schweiz Med Wochenschr; 1969 Aug 23; 99(34):1201-4. PubMed ID: 4897267
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of nicotine in kidney failure.
    Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R.
    Clin Pharmacol Ther; 2000 Sep 23; 68(3):250-60. PubMed ID: 11014406
    [Abstract] [Full Text] [Related]

  • 27. Bromfenac disposition in patients with impaired kidney function.
    Ermer JC, Boni JP, Cevallos WH, DeCleene S, Burghart P, Rudnick MR, Fruncillo RJ, Berns JS, Cohen RM.
    Clin Pharmacol Ther; 1997 Mar 23; 61(3):312-8. PubMed ID: 9084456
    [Abstract] [Full Text] [Related]

  • 28. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE, King JH.
    Ann Pharmacother; 2006 Jan 23; 40(1):9-14. PubMed ID: 16332944
    [Abstract] [Full Text] [Related]

  • 29. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM, Ruscher H, Frankhauser J, Kuntzmann F, Lavillaureix J.
    Pathol Biol (Paris); 1973 Jun 23; 21(6):671-9. PubMed ID: 4581199
    [No Abstract] [Full Text] [Related]

  • 30. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F.
    Clin Nephrol; 1995 Nov 23; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [Abstract] [Full Text] [Related]

  • 31. [Study of ampicillin absorption in patients with chronic kidney failure].
    Lobuseva AN, Vasina TA, Zeĭdlits LA, Levitskiĭ ER, Navashin SM.
    Antibiotiki; 1971 Nov 23; 16(4):350-4. PubMed ID: 4998598
    [No Abstract] [Full Text] [Related]

  • 32. The effect of doxycycline on renal function in patients with advanced renal insufficiency.
    Stenbaek O, Myhre E, Berdal BP.
    Scand J Infect Dis; 1973 Nov 23; 5(3):199-202. PubMed ID: 4767571
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of doxycycline administration in patients with renal failure and in normal subjects.
    Curtis JR, Koutsaimanis KG, Buggey D, Eastwood JB.
    Br J Urol; 1973 Aug 23; 45(4):445-9. PubMed ID: 4729894
    [No Abstract] [Full Text] [Related]

  • 34. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W, Ong-Ajyooth L, Taruangsri P, Pokum S.
    J Med Assoc Thai; 2003 May 23; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [Abstract] [Full Text] [Related]

  • 35. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J, Niewiarowski S, Musial J, Bastl C, Grossman RA, Rao AK, Berman I, Paul D.
    J Lab Clin Med; 1980 Jul 23; 96(1):102-13. PubMed ID: 6446588
    [Abstract] [Full Text] [Related]

  • 36. [Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)].
    Schmidt P, Korn A, Hitzenberger G, Zazgornik J, Kopsa H, Pils P.
    Wien Med Wochenschr; 1980 Feb 29; 130(4):171-3. PubMed ID: 7376686
    [Abstract] [Full Text] [Related]

  • 37. Plasma elimination of cardiac troponin I in end-stage renal disease.
    Ellis K, Dreisbach AW, Lertora JL.
    South Med J; 2001 Oct 29; 94(10):993-6. PubMed ID: 11702827
    [Abstract] [Full Text] [Related]

  • 38. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP, Obineche EN, Khan ST, Abdulle AM.
    Saudi Med J; 2004 Nov 29; 25(11):1611-6. PubMed ID: 15573187
    [Abstract] [Full Text] [Related]

  • 39. [Experimental and clinical studies of methods for regenerating the dialysis solution].
    Eventov VL, Andrianova MIu, Maksimenko VA.
    Urol Nefrol (Mosk); 1995 Nov 29; (4):25-7. PubMed ID: 7571196
    [Abstract] [Full Text] [Related]

  • 40. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
    Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Picetti E, Manini P, Andreoli R, Cabassi A.
    Nephrol Dial Transplant; 2006 May 29; 21(5):1402-6. PubMed ID: 16504979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.